Viewing Study NCT00225420


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2026-01-29 @ 5:26 AM
Study NCT ID: NCT00225420
Status: COMPLETED
Last Update Posted: 2017-06-01
First Post: 2005-09-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the prostate View
None stage I prostate cancer View
None stage II prostate cancer View
None stage III prostate cancer View
None stage IV prostate cancer View